These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Supplementary clinical data on the participation of the external biliary tract in post-viral chronic hepatitis]. PAPPO A; MIRON C; GEORGESCU A; DUMITRIU L Stud Cercet Med Interna; 1962; 3():373-7. PubMed ID: 14483763 [No Abstract] [Full Text] [Related]
6. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003). Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722 [TBL] [Abstract][Full Text] [Related]
7. [Posthepatitis syndrome of the biliary tract examined by a specially adapted duodenal tube]. HERFORT K; KECLIK M Cas Lek Cesk; 1954 Oct; 93(40-41):1096-102. PubMed ID: 13219669 [No Abstract] [Full Text] [Related]
8. [The participation of the bile ducts in chronic post-viral hepatitis]. Buligesco L; Andronesco M; Vasilesco G Lyon Chir; 1966 Sep; 62(5):698-705. PubMed ID: 5974874 [No Abstract] [Full Text] [Related]
9. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Kipnis E; Sawa T; Wiener-Kronish J Med Mal Infect; 2006 Feb; 36(2):78-91. PubMed ID: 16427231 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics of residual menifestations of Botkin's disease in children]. Nisevich NI; Efimova SP Vopr Okhr Materin Det; 1968 Jul; 13(7):25-30. PubMed ID: 5720188 [No Abstract] [Full Text] [Related]
12. [Significance of cholestasis for the therapy and prognosis of infectious hepatitis]. Semmler H; Mittmann W Dtsch Gesundheitsw; 1968 Nov; 23(45):2127-30. PubMed ID: 5730924 [No Abstract] [Full Text] [Related]
13. [Primary choledochitis as a complication of infectious hepatitis]. Tkacz B; Fabianowski J Przegl Lek; 1967; 23(4):378-80. PubMed ID: 6043458 [No Abstract] [Full Text] [Related]
14. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa. Cachia PJ; Hodges RS Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116 [TBL] [Abstract][Full Text] [Related]
15. [1st personal experiences with carbenicillin therapy of urinary tract infections due to Pseudomonas aeruginosa]. De Rosa F G Mal Infett Parassit; 1971 Nov; 23(11):1068-70. PubMed ID: 5004854 [No Abstract] [Full Text] [Related]
16. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. Mittal R; Sharma S; Chhibber S; Harjai K J Biomed Sci; 2008 Nov; 15(6):731-41. PubMed ID: 18688758 [TBL] [Abstract][Full Text] [Related]
17. [Role of pyocine typing in the control of Pseudomonas aeruginosa urinary tract infections]. Neussel H Arzneimittelforschung; 1971 Mar; 21(3):333-5. PubMed ID: 4994437 [No Abstract] [Full Text] [Related]
18. [Treating the wound infected by Pseudomonas aeruginosa and hepatitis virus]. Maeyama M Kango Gijutsu; 1983 Oct; 29(13):1766-71. PubMed ID: 6417378 [No Abstract] [Full Text] [Related]
19. [On the incidence of pyocyanic infections (Pseudomonas aeruginosa) at the Spedale di Santa Maria degli Innocenti]. Cerofolini PL; Pastorini M; Silli U Riv Clin Pediatr; 1969; 82(2):61-3. PubMed ID: 4994077 [No Abstract] [Full Text] [Related]
20. [Acute and chronic biliary tract infections. Studies of the therapeutic effect of a new broad-spectrum cephalosporin]. Eisenburg J Fortschr Med; 1983 Aug; 101(31-32):1407-12. PubMed ID: 6618404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]